Brinton gets nod from DCGI for favipiravir in India

Pharma Company, Brinton Pharmaceuticals has received green signal from Drugs Controller General of India (DCGI) for marketing of favipiravir under the brand name faviton. The drug will be marketed in India and exported globally by the company and will be available in 200 mg tablets.

Favipiravir is an effective treatment option in the management of mild-to-moderate COVID-19 as per clinical evidence. The medicine is an orally-administered medication and more convenient compared to intravenously-administered medicines.

Rahul Kumar Darda, CMD, Brinton Pharmaceuticals, said, “We always wanted to launch “evidence-based cure” to combat COVID-19. Our strategic intent will be to improve the access through our strong distribution network that will help make faviton available across all COVID treatment centres and our MRP is Rs 59 per tablet”.

The drug will be available in a strip of 10 tablets and 50 tablets in a box.

  • Related Posts

    NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

    The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 30 drug formulations, including Vitamin D3 oral solution, calcium and vitamin supplements, anti-diabetic medicines, cardiovascular drugs and immunosuppressant…

    Maharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in ads

    Maharashtra’s Food and Drug Administration has confiscated medicines worth more than ₹73 lakh, including Patanjali-linked products valued at over ₹51 lakh, in a statewide drive against misleading advertisements and misbranded…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

    NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

    Maharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in ads

    Maharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in ads

    Industry asks NPPA to implement SOTS Scheme to resolve pending litigations

    Industry asks NPPA to implement SOTS Scheme to resolve pending litigations

    A Non- Smoker Smoking Hot Spouse needed for Actress Neetu Chandra

    A Non- Smoker Smoking Hot Spouse needed for Actress Neetu Chandra

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad